Raporty
18/2011 Closing of subscription and sale- supplementary report
Taking into account closing of the public offering, the Management Board of CENTRUM MEDYCZNE ENEL-MED S.A. with its registered office in Warsaw (Issuer) would like to present the information on closing of subscription and allocation of shares:
1. Subscription start date: 24 May 2011, subscription closing date: 31 May 2011
2. Date of securities allocation: 1 June 2011
3. Number of securities subject to subscription and sale: 7,100,000 shares, including:
a) in the Institutional Tranche: 5,600,000 shares series D;
b) in the Retail Tranche: 1,500,000 shares series D.
4. Subscription reduction rates:
a) in the Institutional Tranche: 0%,
b) in the Retail Tranche: 22.72%.
5. Number of shares subscribed for during the subscription: 7,541,063.
6. Number of shares allocated as a result of the subscription: 7,100,000.
7. Issue price: PLN 5.00
8. Number of persons that subscribed for shares:
a) in the Institutional Tranche: 28 (including two entities managing third parties’ securities packages on behalf of 426 clients);
b) in the Retail Tranche: 1,736.
9. Number of persons to whom the shares were allocated:
28 (including two entities managing third parties’ securities packages on behalf of 426 clients);
b) in the Retail Tranche: 1,736.
10. Shares not taken by sub-issuers (no sub-issue agreements were concluded).
11. Value of subscription and sale: PLN 35,500,000
12. As at 13 June 2011, total costs of issue of shares series D equal: PLN 3,514,061.86, including:
a) offering preparation and implementation: PLN 674,000.00 gross;
b) sub-issuer fee: PLN 0;
c) prospectus preparation, including advisory costs: PLN 1,884,442.62 gross;
d) offering promotion: PLN 955,619.24 gross.
The method of settlement of the issue costs in the accounting records and the method of their recognition in the financial statements: the issue costs will reduce the supplementary capital of the Issuer resulting from the premium on issue of shares above their nominal value.
13. Average subscription cost per share series D: PLN 0.49.
Legal basis: § 33 of Regulation of 19 October 2005 of the Minister of Finance on current and periodical information submitted by issuers of securities.